Metabolic Profiling Reveals Diagnostic Biomarkers for Distinguishing Myocarditis From Acute Myocardial Infarction
Conclusions: In conclusion, patients experiencing AMI and MC undergo significant metabolic reprogramming. Metabolites exhibiting abnormal expression in peripheral blood hold diagnostic value for distinguishing between AMI and MC in clinical settings. 11-cis-retinol proved to be the pivotal biomarker...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2025-01-01
|
| Sarja: | Cardiovascular Therapeutics |
| Linkit: | http://dx.doi.org/10.1155/cdr/6292099 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|